JANUS HENDERSON GROUP PLC OWNS 7.4% OF ARCA BIOPHARMA, INC

Company

Oruka Therapeutics, Inc.

Filed

April 11, 2024

Accession Number

0001274173-24-000067

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →